From the inbox, subject "Please could I call you to discuss your recent research?"
My name is [redacted], the Business Development Director of a leading custom antibody company. If you have any interest in custom antibodies (monoclonal or polyclonal), is it possible to arrange some time to discuss how our innovative technologies could assist your research?
With us, generating custom monoclonal antibody starts as simple as sending us the sequence or accession number. We will perform a throughout analyze the targeted protein, prepare a detailed project plan and quote for your review.
Through 6 years of focused work in custom antibody production, we collaborated with around 2,100 researchers world-wide and hundreds of top papers cited our antibodies. We are looking forward to working with you for an enjoyable partnership.
Thank you very much and looking forward to your reply
My reply?
Unfortunately I am not antibody. I am probody.
